These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Reported results 2004-002902-31 A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia with a Focus on Methicillin Resistant ... 2007-07-11 due-trials
Reported results 2004-002904-13 A Phase 3, Randomized, Double-Blind, Parallel-Group, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Hospital-Acquired Pneumonia with a Focus on Patients with Infectio... 2007-10-20 due-trials
Reported results 2004-002910-12 A Phase 3, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram-Positive Skin and Skin Structure Infections with a focus on Patie... 2006-06-12 due-trials
Reported results 2004-002914-12 A Phase 3, Randomized, Double-Blind, Multinational Trial of Intravenous Telavancin Versus Vancomycin for Treatment of Complicated Gram-positive Skin and Skin Structure Infections with a Focus on Patie... 2006-06-15 due-trials
Reported results 2012-004949-32 A Phase 2, Randomised, Double-Blind, Multiple−Dose, Five−Period, Incomplete-Block, Crossover Study to Examine the Pharmacodynamics, Safety and Tolerability, and Pharmacokinetics of Multiple Doses of T... 2014-08-23 due-trials
Reported results 2014-003250-13 A Multicenter, Double-Blind, Randomized, Placebo-Controlled, Parallel-Group Phase 2 Study to Assess the Efficacy, Safety, and Tolerability of Velusetrag for the Treatment of Diabetic or Idiopathic Gas... 2017-06-05 due-trials
Listed as ongoing, but also has a completion date 2014-004372-27 A Phase 3 Multicenter, Randomized, Open-label, Clinical Trial of Telavancin Versus Standard Intravenous Therapy in the Treatment of Subjects with Staphylococcus aureus Bacteremia Including Infective E... 2018-04-12 bad-data
Trial is outside EEC 2015-002218-60 An Open-Label Study of the Pharmacokinetics of a Single Dose of Telavancin in Pediatric Subjects Aged 1 to 17 Years bad-data
Listed as ongoing, but also has a completion date and reported results 2018-001272-37 A Phase 2 Multi-Center, Randomized, Double-Blind, Placebo-controlled, Parallel-Group Study to Evaluate the Efficacy and Safety of Induction Therapy with 2 Doses of TD-1473 in Subjects with Moderately-... 2023-03-30 bad-data
Reported results 2018-002135-19 A 3-Year, Multi-Center, Long-Term Safety (LTS) Study to Evaluate the Safety and Tolerability of TD-1473 in Subjects with Ulcerative Colitis (UC) 2021-09-01 due-trials
Listed as ongoing, but also has a completion date and reported results 2018-002136-24 A Phase 2b/3 Multi-Center, Randomized, Double-Blind, Multi-Dose, Placebo-Controlled, Parallel-Group Set of Studies to Evaluate the Efficacy and Safety of Induction and Maintenance Therapy with TD-1473... 2021-09-01 bad-data
Listed as ongoing, but also has a completion date and reported results 2018-003289-15 A Phase 3, 4-week, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects With Primary Autono... 2021-07-21 bad-data
Listed as ongoing, but also has a completion date and reported results 2018-003941-41 A Phase 3, 22-week, Multi-center, Randomized Withdrawal Study of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension in Subjects with Primary Autonomic Failure 2021-11-10 bad-data
Listed as ongoing, but also has a completion date and reported results 2019-002425-30 A Phase 3, 182-week, Open-Label, Extension Study to Investigate the Safety and Tolerability of TD-9855 in Treating Symptomatic Neurogenic Orthostatic Hypotension (symptomatic nOH) in Subjects with Pri... 2021-11-12 bad-data
Reported results 2019-002915-24 A Randomized, Double-blind, Placebo-controlled, 3-period Crossover Study to Evaluate the Effects of Repeated Doses of Inhaled TD-8236 and Impact on Airway Responses Following Allergen Challenge in Pat... 2020-08-28 due-trials
Listed as ongoing, but also has a completion date and reported results 2020-001807-18 A Phase 2, Randomized, Double-Blind, Placebo-Controlled, Parallel-group, Multi-center Study of an Inhaled Pan-Janus Kinase Inhibitor, TD-0903, to Treat Symptomatic Acute Lung Injury Associated with CO... 2021-04-21 bad-data